Weiss Ratings Reiterates "Sell (D-)" Rating for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Key Points

• Weiss Ratings has reiterated a "sell (D-)" rating for Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC), indicating ongoing concerns about the company's performance.
• OACC shares opened at $10.56, reflecting slight volatility with a one-year range between $9.95 and $10.85.
• Recent institutional investments indicate a significant interest in Oaktree Acquisition Corp., with firms like Clear Street LLC increasing their stakes by over 265% in the second quarter.

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Get Free Report)'s stock had its "sell (d-)" rating restated by Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.3%

OACC stock opened at $10.56 on Wednesday. The business's 50-day moving average is $10.46 and its two-hundred day moving average is $10.41. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $9.95 and a 1 year high of $10.85.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Clear Street LLC boosted its stake in shares of Oaktree Acquisition Corp. III Life Sciences by 265.1% in the second quarter. Clear Street LLC now owns 22,000 shares of the company's stock valued at $230,000 after buying an additional 15,975 shares in the last quarter. Meteora Capital LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the second quarter valued at $517,000. Kepos Capital LP acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the first quarter valued at $563,000. Picton Mahoney Asset Management acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the first quarter valued at $767,000. Finally, Radcliffe Capital Management L.P. acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the second quarter valued at $856,000.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.